Lung TB: Higher Dose Of Rifampicin Safe, Can Boost Recurrence-Free Survival, Says ICMR Study
New Delhi: A higher dose of rifampicin — a bactericidal antibiotic used primarily to treat tuberculosis (TB) — may be safe, and its use can potentially lead to recurrence-free survival in patients with pulmonary TB, according to a recent study by the Indian Council of Medical Research (ICMR).TB is curable but still remains the most common…
